JPRN-UMIN000021123已完成未知
Efficacy and safety of Ombitasvir/Paritaprevir/Ritonavir in chronic hepatitis C patients - Efficacy of Ombitasvir/Paritaprevir/Ritonavir in chronic hepatitis C patients
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Decompensated cirrhosis, Liver failure (2)patients with hepatic cell carcinoma (3) Co-infection with hepatitis B virus Co-infection with anti- humanimmunodeficiency virus
研究者
相似试验
招募中
不适用
Efficacy and safety of ombitasvir/paritaprevir/ritonavir, ledipasvir/sofosbuvir, elbasvir /grazoprevir, glecaprevir/pibrentasvir after curative treatment of HCV-Related HCC - Prospective multicenter-cooperative cohort studyHCV-related hepatocellular carcinomaJPRN-UMIN000025085Juntendo University Hospital80
尚未招募
不适用
Efficacy and safety of paritaprevir and ombitasvir in patients with chronic hepatitis CJPRN-UMIN000020019Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology2,000
已完成
不适用
Prospective study of Ombitasvir/Paritaprevir/Ritonavir for HCV genotype 1 intected Japanese patients including patients with chronic kidney diseaseHCV genotype 1 infected chronic liver diseaseJPRN-UMIN000020626Osaka City University and affiliated hospital200
招募中
不适用
Evaluation of the efficacy of ombitasvir and paritaprevir with ritonavir for Japanese hepatitis C patients: a prospective study in real-life settings.chronic hepatitis CJPRN-UMIN000021276Toranomon Hospital100
已完成
不适用
Efficacy and Safety of Ombitasvir plus Paritaprevir/r combination regimen for Hepatitis C infected patients with immune disordersPatients with genotype 1 HCV infection who have immune disorderJPRN-UMIN000020302Hokkaido University50